Pharma Equity Group
0.10 DKK
Less than 1K followers
PEG
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
-0.99 %
-15.61 %
-25.09 %
-15.25 %
-47.37 %
-45.65 %
-77.78 %
-78.95 %
-99.62 %
Pharma Equity Group develops medicines for the treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The Company uses repositioning of existing medicines and takes drug candidates to a clinical Phase III stage, after which they are handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the Company.
Read moreMarket cap
122.76M DKK
Turnover
-
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Latest research
Latest analysis report
Released: 2025-09-10
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S
Pharma Equity Group A/S’ agreement with Danske Bank as liquidity provider will terminate on 1 January 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
